Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 10.76% is 59% below its 4-year average of 26.24%, near the low end of its 4-year range (10.76%–103.00%).
As of the fiscal period ended Tuesday, March 31, 2026. 65.33% below its 12-month average of 31.04%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
10.76%
EBITDA MARGIN AVG TTM
31.04%
EBITDA MARGIN AVG 3Y
19.95%
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-65.33%
CURRENT VS 3Y AVG
-46.04%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Solventum Corporation
Market Cap
$15.12B
EBITDA Margin
10.76%
TTM Avg
31.04%
3Y Avg
19.95%
5Y Avg
N/A
Market Cap
$14.18B
EBITDA Margin
27.02%
TTM Avg
27.38%
3Y Avg
26.41%
5Y Avg
26.36%
Market Cap
$16.07B
EBITDA Margin
22.25%
TTM Avg
22.41%
3Y Avg
21.18%
5Y Avg
20.68%
Market Cap
$12.83B
EBITDA Margin
19.75%
TTM Avg
19.29%
3Y Avg
19.87%
5Y Avg
21.06%
Market Cap
$12.78B
EBITDA Margin
5.99%
TTM Avg
7.75%
3Y Avg
3.55%
5Y Avg
8.89%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $15.12B | 10.76% | 31.04% | 19.95% | N/A |
| DaVita Inc. (DVA)vs › | $15.51B | 19.98% | 20.97% | 19.78% | 20.10% |
| The Cooper Companies, Inc. (COO)vs › | $14.18B | 27.02% | 27.38% | 26.41% | 26.36% |
| Medpace Holdings, Inc. (MEDP)vs › | $16.07B | 22.25% | 22.41% | 21.18% | 20.68% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 24.73% | 27.15% | 30.37% | 35.33% |
| Align Technology, Inc. (ALGN)vs › | $12.83B | 19.75% | 19.29% | 19.87% | 21.06% |
| Baxter International Inc. (BAX)vs › | $12.78B | 5.99% | 7.75% | 3.55% | 8.89% |
| Revvity, Inc. (RVTY)vs › | $12.34B | 23.07% | 26.75% | 30.05% | 32.80% |
| Insulet Corp. (PODD)vs › | $11.75B | 21.67% | 20.24% | 16.36% | 15.66% |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.51B | 22.69% | 18.62% | 20.95% | 21.80% |
Gross Margin
53.7%
EBITDA Margin
10.8%
Operating Margin
25.5%
Net Margin
17.3%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | 10.76% |
| 2025-12-31 | 103.00% |
| 2025-09-30 | 12.31% |
| 2025-06-30 | 15.55% |
| 2025-03-31 | 13.57% |
| 2024-12-31 | 13.78% |
| 2024-09-30 | 19.60% |
| 2024-06-30 | 18.12% |
| 2024-03-31 | 25.79% |
| 2023-12-31 | 26.77% |
| 2023-09-30 | 31.24% |
| 2023-06-30 | 26.49% |
| 2023-03-31 | 25.36% |
| 2022-12-31 | 18.83% |
| 2022-09-30 | 28.12% |
| 2022-06-30 | 28.43% |
| 2022-03-31 | 28.43% |
